New hope for advanced cervical cancer: volrustomig trial underway
NCT ID NCT06943833
First seen Sep 30, 2025 · Last updated May 15, 2026 · Updated 22 times
Summary
This study tests a drug called volrustomig in 30 women with advanced cervical cancer (stage IIIA to IVA) who have finished standard chemoradiation without their cancer getting worse. The goal is to see if volrustomig can help keep the cancer from returning or spreading. Participants receive the drug and are monitored for side effects and cancer progression over several years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Arkhangelsk, 163045, Russia
-
Research Site
Krasnoyarsk, 660133, Russia
-
Research Site
Moscow, 111123, Russia
-
Research Site
Moscow, 115478, Russia
-
Research Site
Moscow, 115533, Russia
-
Research Site
Moscow, 117997, Russia
-
Research Site
Moscow, 125284, Russia
-
Research Site
Moscow, 125367, Russia
-
Research Site
Saint Petersburg, 194291, Russia
-
Research Site
Saint Petersburg, 197758, Russia
-
Research Site
Ufa, 450054, Russia
-
Research Site
Yekaterinburg, 620036, Russia
Conditions
Explore the condition pages connected to this study.